FDA Should Allow Multiple Extensions For PMA Major Deficiencies – AdvaMed
This article was originally published in The Gray Sheet
Executive Summary
MDUFMA performance goal review metrics outlined in agency guidance should be binding, and therefore established "through notice and comment rulemaking," AdvaMed contends